Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kirnbauer

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Archives of Dermatology|March 3, 1999
Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic toolP Lenz, M Amagai, B Volc-Platzer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1992
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenicR Kirnbauer, F Booy, N Cheng, et al.
Archives of Dermatology|June 29, 2000
Regression of deeply infiltrating giant condyloma (Buschke-Löwenstein tumor) following long-term intralesional interferon alfa therapyA Geusau, G Heinz-Peer, B Volc-Platzer, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Keratinocyte-derived interleukin 3T A Luger, A Kock, R Kirnbauer, et al.
Progress in Clinical and Biological Research|January 1, 1989
Serum proteins and cytokines for prediction of sepsis?A F Hammerle, G Pöschl, R Kirnbauer, et al.
Journal of Medical Virology|August 1, 1995
Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infectionA Wikström, G J van Doornum, R Kirnbauer, et al.
The Journal of Investigative Dermatology|December 1, 1988
Detection of a specific inhibitor of interleukin 1 in sera of UVB-treated miceT Schwarz, A Urbanski, R Kirnbauer, et al.
Current Problems in Dermatology|January 1, 1990
Cytokines and the skinT A Luger, T Schwarz, J Krutmann, et al.
Virology|April 9, 2008
A subset of equine sarcoids harbours BPV-1 DNA in a complex with L1 major capsid proteinS Brandt, R Haralambus, S Shafti-Keramat, et al.
Equine Veterinary Journal|September 8, 2011
Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horsesE K Hainisch, S Brandt, S Shafti-Keramat, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Archives of Dermatology|March 3, 1999
Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic toolP Lenz, M Amagai, B Volc-Platzer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1992
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenicR Kirnbauer, F Booy, N Cheng, et al.
Archives of Dermatology|June 29, 2000
Regression of deeply infiltrating giant condyloma (Buschke-Löwenstein tumor) following long-term intralesional interferon alfa therapyA Geusau, G Heinz-Peer, B Volc-Platzer, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Keratinocyte-derived interleukin 3T A Luger, A Kock, R Kirnbauer, et al.
Progress in Clinical and Biological Research|January 1, 1989
Serum proteins and cytokines for prediction of sepsis?A F Hammerle, G Pöschl, R Kirnbauer, et al.
Journal of Medical Virology|August 1, 1995
Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infectionA Wikström, G J van Doornum, R Kirnbauer, et al.
The Journal of Investigative Dermatology|December 1, 1988
Detection of a specific inhibitor of interleukin 1 in sera of UVB-treated miceT Schwarz, A Urbanski, R Kirnbauer, et al.
Current Problems in Dermatology|January 1, 1990
Cytokines and the skinT A Luger, T Schwarz, J Krutmann, et al.
Virology|April 9, 2008
A subset of equine sarcoids harbours BPV-1 DNA in a complex with L1 major capsid proteinS Brandt, R Haralambus, S Shafti-Keramat, et al.
Equine Veterinary Journal|September 8, 2011
Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horsesE K Hainisch, S Brandt, S Shafti-Keramat, et al.
Pageof 6